OLEMA PHARMACEUTICALS INC. - COMMON STOCK

Olema Oncology to Present New Palazestrant Clinical Data in Combination with CDK4/6 Inhibitors at the 2023 San Antonio Breast Cancer Symposium (SABCS)

28 ноя 2023 16:10:00 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update

07 ноя 2023 15:02:00 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 ноя 2023 15:32:00 Источник Nasdaq GlobeNewswire

Olema Oncology to Participate in Upcoming Investor Conferences in November

01 ноя 2023 15:27:00 Источник Nasdaq GlobeNewswire

Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant

22 окт 2023 01:55:00 Источник Nasdaq GlobeNewswire

Olema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of Directors

17 окт 2023 06:01:00 Источник Nasdaq GlobeNewswire

Olema Oncology Announces Phase 2 Monotherapy Clinical Results to be Presented at the 2023 ESMO Congress

16 окт 2023 06:02:00 Источник Nasdaq GlobeNewswire

Olema Oncology KAT6 Inhibitor Compounds Demonstrate Potent Anti-Tumor Activity

12 окт 2023 06:01:00 Источник Nasdaq GlobeNewswire

Olema Oncology Announces Expansion of Collaboration Agreement with Novartis

10 окт 2023 06:00:00 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 окт 2023 15:30:00 Источник Nasdaq GlobeNewswire

Olema Oncology Announces New Preclinical KAT6 Inhibitor Data to be Presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

20 сен 2023 06:29:20 Источник Nasdaq GlobeNewswire

Olema Oncology to Participate in Upcoming Investor Conferences

06 сен 2023 15:30:55 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 сен 2023 15:30:00 Источник Nasdaq GlobeNewswire

Olema Oncology Announces Combined Financing for Up to $180 Million

05 сен 2023 06:30:49 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update

08 авг 2023 15:03:07 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 авг 2023 15:30:34 Источник Nasdaq GlobeNewswire

Olema Oncology to Present at the Canaccord Genuity 43rd Annual Growth Conference

01 авг 2023 07:00:10 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 июл 2023 06:30:32 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 июн 2023 15:30:23 Источник Nasdaq GlobeNewswire

Olema Oncology to Present at the 2023 Jefferies Healthcare Conference

30 май 2023 15:30:43 Источник Nasdaq GlobeNewswire